T. Rowe Price Associates’s Kyverna Therapeutics KYTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.62M | Buy |
1,830,501
+1,250,897
| +216% | +$3.84M | ﹤0.01% | 1244 |
|
|
2025
Q1 | $1.12M | Sell |
579,604
-14,084
| -2% | -$27.2K | ﹤0.01% | 1895 |
|
|
2024
Q4 | $2.22M | Sell |
593,688
-34,534
| -5% | -$129K | ﹤0.01% | 1590 |
|
|
2024
Q3 | $3.07M | Sell |
628,222
-41,335
| -6% | -$202K | ﹤0.01% | 1445 |
|
|
2024
Q2 | $5.02M | Sell |
669,557
-260,077
| -28% | -$1.95M | ﹤0.01% | 1224 |
|
|
2024
Q1 | $23.1M | Buy |
+929,634
| New | +$23.1M | ﹤0.01% | 946 |
|